Perfusion Magnetic Resonance Imaging Predicts Patient Outcome as an Adjunct to Histopathology: A Second Reference Standard in the Surgical and Nonsurgical Treatment of Low-grade Gliomas
- 1 June 2006
- journal article
- duplicate publication
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 58 (6) , 1099-1107
Abstract
OBJECTIVE:. To determine whether relative cerebral blood volume (rCBV) can predict patient outcome, specifically tumor progression, in low-grade gliomaKeywords
This publication has 27 references indexed in Scilit:
- Dynamic, contrast‐enhanced perfusion MRI in mouse gliomas: Correlation with histopathologyMagnetic Resonance in Medicine, 2003
- Low grade glial neoplasmsJournal of Clinical Neuroscience, 2003
- Limitations of stereotactic biopsy in the initial management of gliomasNeuro-Oncology, 2001
- Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumorsCancer, 2000
- Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.American Journal of Roentgenology, 1998
- Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytomaJournal of Neurosurgery, 1998
- The management of histologically unverified presumed cerebral gliomas with radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Contrast agents and cerebral hemodynamicsMagnetic Resonance in Medicine, 1991
- Perfusion imaging with NMR contrast agentsMagnetic Resonance in Medicine, 1990
- Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheresJournal of Neurosurgery, 1987